NCAPD2
protein-codingnon-SMC condensin I complex subunit D2, the group of Armadillo like helical domain containing|Condensin I subunits
Gene summary
Enables histone binding activity. Involved in mitotic chromosome condensation and positive regulation of chromosome condensation. Located in condensed chromosome; cytosol; and nuclear lumen. Part of condensin complex. Implicated in primary autosomal recessive microcephaly 21. [provided by Alliance of Genome Resources, Jun 2026]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~38.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: Unknown
Disease ID:MONDO:0054804
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0054804
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0054804
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to NCAPD2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_014865.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 15 | 7 | 23 | ||
| missense | 1 | 226 | 26 | 3 | 256 | |
| nonsense | 2 | 5 | 7 | |||
| start loss | 0 | |||||
| frameshift | 5 | 2 | 7 | |||
| splice donor/acceptor (+/-2bp) | 2 | 2 | 9 | 13 | ||
| Total | 2 | 10 | 243 | 41 | 10 | 306 |
Highest pathogenic variant AF is 0.00048963947
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_055680.3 | 31 | MANE Select | |
| Ensembl | ENSP00000325017.5 | 31 | MANE Select | |
| Ensembl | ENSP00000371895.4 | 20 | Standard | |
| Ensembl | ENSP00000438495.1 | 3 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| ncapd2 | Danio rerio | Structure: head Quality: decreased size abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- akap95 role in mitosis and chromosome dynamics
- Condensation of Prometaphase Chromosomes
- Mitotic Prometaphase
- M Phase
- Cell Cycle
Biological Process
- mitotic chromosome condensation
- meiotic chromosome condensation
- cell division
- chromosome separation
Molecular Function
- chromatin binding
- protein binding
- histone binding
Cellular Component
- nuclear chromosome
- condensed chromosome, centromeric region
- condensed chromosome
- condensin complex
- condensin core heterodimer
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000315579
- Coding exons
- 31
- Length
- 38600
- Individuals with no LoFs
- 125535
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 213
- Defined
- 125748
- p
- 0.000847
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.709 | 743 | 799 | 0.929 | 0.0000462 | 9124 |
| Missense (PolyPhen) | 189 | 218.25 | 0.86599 | 2560 | ||
| Synonymous | 0.262 | 288 | 294 | 0.981 | 0.0000149 | 2826 |
| Loss of Function | 4.60 | 34 | 77.8 | 0.437 | 0.00000447 | 828 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00068 | 0.00068 | rare |
| Latino/Admixed American | 0.00093 | 0.00093 | rare |
| Ashkenazi Jewish | 0.0023 | 0.0023 | notable |
| East Asian | 0.00033 | 0.00033 | rare |
| Finnish | 0.00051 | 0.00051 | rare |
| European (Non-Finnish) | 0.00096 | 0.00096 | rare |
| South Asian | 0.00056 | 0.00056 | rare |
| Other | 0.00065 | 0.00065 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Regulatory subunit of the condensin complex, a complex required for conversion of interphase chromatin into mitotic-like condense chromosomes. The condensin complex probably introduces positive supercoils into relaxed DNA in the presence of type I topoisomerases and converts nicked DNA into positive knotted forms in the presence of type II topoisomerases. May target the condensin complex to DNA via its C-terminal domain. {ECO:0000269|PubMed:11136719}.;
Recessive Scores
- pRec
- 0.120
Intolerance Scores
- LoFtool
- 0.771
- RVIS EVS
- -0.05
- RVIS percentile EVS
- 48.95
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.526
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |